Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia.

Chen, Yun; Chen, Liguang; Yu, Jian; Ghia, Emanuela M; Choi, Michael Y; Zhang, Ling; Zhang, Suping; Sanchez-Lopez, Elsa; Widhopf, George F; Messer, Karen; Rassenti, Laura Z; Jamieson, Catriona; Kipps, Thomas J.
Blood; 134(13): 1084-1094, 2019 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-31409670

Não foram localizados documentos relacionados